A study of the efficacy of glutamine and prebiotics in the patients with inflammatory bowel disease

A study of the efficacy of glutamine and prebiotics in the patients with inflammatory bowel disease - Efficacy of glutamine and prebiotics in the patients with inflammatory bowel disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004306

Enrollment

Registered

2010-10-01

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

Each subject will take GFO 3packs/day, thrice daily with meal for 30 days.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with ulcerative colotis 2) Patients who can gave written consents by herself or himself

Exclusion criteria

Exclusion criteria: 1) Patients who have severe hepatic or renal disease 2) Patients whose conditions of ulcerative colitis are unstable 3) Patients who have history of gastrectomy or extensive enterectomy 4) Patients who have malignant tumor under treatment 5) Patients who are judged as not appropriate for participation

Design outcomes

Primary

Measure	Time frame
Improvement of intestinal inflammation	—

Secondary

Measure	Time frame
Circulating levels of GLP-2 and incretins	—

Countries

Japan

Contacts

Public ContactAkihiro Hamasaki

Graduate School of Medicine, Kyoto University Department of Diabetes and Clinical Nutrition

075-751-3560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026